1.08
Oragenics Inc stock is traded at $1.08, with a volume of 81,668.
It is up +1.89% in the last 24 hours and down -18.18% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.06
Open:
$1.06
24h Volume:
81,668
Relative Volume:
0.17
Market Cap:
$4.46M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1265
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
+4.85%
1M Performance:
-18.18%
6M Performance:
-87.14%
1Y Performance:
-93.14%
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OGEN
Oragenics Inc
|
1.08 | 4.37M | 0 | -20.26M | -8.25M | -8.54 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Stock (OGEN) Latest News
What recovery options are there for Oragenics Inc.Weekly Stock Summary & Entry Point Confirmation Signals - Newser
Tools to assess Oragenics Inc.’s risk profileCPI Data & Weekly Top Performers Watchlists - Newser
News impact scoring models applied to Oragenics Inc.2025 Key Highlights & Weekly High Return Opportunities - Newser
Is Oragenics Inc. a defensive stock2025 Investor Takeaways & Capital Protection Trading Alerts - خودرو بانک
Will Oragenics Inc. benefit from AI trendsJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - خودرو بانک
Is Oragenics Inc. a top pick in the sectorJuly 2025 Breakouts & Low Drawdown Investment Strategies - خودرو بانک
Will Oragenics Inc. benefit from government policyJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - خودرو بانک
Oragenics Inc. stock momentum explained2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Can Oragenics Inc. deliver consistent dividends2025 Major Catalysts & Intraday High Probability Setup Alerts - خودرو بانک
Will Oragenics Inc. benefit from geopolitical trendsWeekly Profit Analysis & Risk Controlled Stock Pick Alerts - خودرو بانک
Can Oragenics Inc. maintain sales growth2025 Sector Review & Technical Buy Zone Confirmations - 강소기업뉴스
Key resistance and support levels for Oragenics Inc.July 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Price momentum metrics for Oragenics Inc. explained2025 Top Gainers & Smart Allocation Stock Tips - Newser
What Fibonacci levels say about Oragenics Inc. rebound2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Is Oragenics Inc. in a consolidation phaseJuly 2025 Summary & Free Real-Time Volume Trigger Notifications - 더경남뉴스
Can technical indicators confirm Oragenics Inc.’s reversal2025 Support & Resistance & Verified Swing Trading Watchlists - Newser
Analyzing drawdowns of Oragenics Inc. with statistical tools2025 Support & Resistance & Reliable Breakout Forecasts - Newser
Short Squeeze: Is now the right time to enter Oragenics Inc.Options Play & AI Powered Trade Plan Recommendations - خودرو بانک
Oragenics Appoints Natasha Giordano to Board of Directors - The Globe and Mail
Is now the right time to enter Oragenics Inc.Market Sentiment Report & Weekly High Potential Stock Alerts - خودرو بانک
What data driven models say about Oragenics Inc.’s future2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
Is Oragenics Inc. subject to activist investor interest2025 Historical Comparison & Weekly Stock Performance Updates - خودرو بانک
Real time scanner hits for Oragenics Inc. explainedJuly 2025 Reactions & Technical Pattern Alert System - Newser
What is the earnings history of Oragenics Inc.Weekly Trend Report & Low Volatility Stock Suggestions - khodrobank.com
Should value investors consider Oragenics Inc.Dividend Hike & Weekly Market Pulse Updates - خودرو بانک
Is Oragenics Inc. stock showing strong momentumJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - خودرو بانک
Oragenics appoints Natasha Giordano to board of directors - Investing.com
Buyout Rumor: Is Oragenics Inc. stock showing strong momentumJuly 2025 Pullbacks & Technical Pattern Alert System - خودرو بانک
Risk adjusted return profile for Oragenics Inc. analyzedDay Trade & Weekly Return Optimization Plans - Newser
Will Oragenics Inc. price bounce be sustainableTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Oragenics Inc. stock trend forecast2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - Newser
Will a bounce in Oragenics Inc. offer an exit2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
News impact scoring models applied to Oragenics Inc2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Using fundamentals and technicals on Oragenics Inc.July 2025 Trends & Target Return Focused Stock Picks - Newser
How sentiment analysis helps forecast Oragenics Inc.Weekly Stock Report & High Accuracy Swing Trade Signals - Newser
How to use a screener to detect Oragenics Inc. breakoutsLayoff News & Real-Time Volume Surge Alerts - Newser
Smart tools for monitoring Oragenics Inc.’s price actionWeekly Risk Report & AI Forecasted Entry and Exit Points - Newser
Chart based analysis of Oragenics Inc. trends2025 Big Picture & Safe Entry Momentum Tips - Newser
What technical models suggest about Oragenics Inc.’s comebackWeekly Gains Report & AI Powered Market Trend Analysis - Newser
Can Oragenics Inc. maintain sales growth getLinesFromResByArray error: size == 0 - 시사인 투데이
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):